跳至主要内容
临床试验/TCTR20180610001
TCTR20180610001已完成未知

Comparison of topical recombinant human epidermal growth factor versus aloe vera gel in combination with ablative 10,600-nm carbon dioxide fractional laser for the treatment of striae alba: A randomized, double-blind trial

Thammasat University0 个研究点目标入组 24 人开始时间: 2018年6月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 60 Years(—)
性别
All

入选标准

  • subjects aged 20-60, in good health, with striae alba on both sides of abdomen, thigh or buttock, able to remain 5kg of their starting weight during the study and avoid any non-study treatment of striae during the whole study period

排除标准

  • history of keloids or hypertrophic scar, skin infection or other active skin disease on the study areas, use of immunosuppressive drug or systemic retinoid within past 2 months, any treatment including laser for striae within 1 year prior to study initiation, allergy to local anesthesia (e.g. lidocaine or prilocaine).

研究者

相似试验